scispace - formally typeset
R

Ross L. Prentice

Researcher at Fred Hutchinson Cancer Research Center

Publications -  407
Citations -  37908

Ross L. Prentice is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Breast cancer & Women's Health Initiative. The author has an hindex of 94, co-authored 407 publications receiving 33619 citations. Previous affiliations of Ross L. Prentice include Argonne National Laboratory & Radiation Effects Research Foundation.

Papers
More filters
Journal ArticleDOI

Estrogen Plus Progestin and Risk of Venous Thrombosis—Reply

TL;DR: Estrogen plus progestin therapy was associated with doubling the risk of venous thrombosis and the risks associated with age, overweight or obesity, and factor V Leiden were increased.
Journal ArticleDOI

Regression calibration in failure time regression.

TL;DR: A regression calibration method for failure time regression analysis when data on some covariates are missing or mismeasured and compared with an estimated partial likelihood estimator via simulation studies, where the proposed method performs well even though it is technically inconsistent.
Journal ArticleDOI

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

Lang Wu, +234 more
- 18 Jun 2018 - 
TL;DR: A transcriptome-wide association study evaluating associations of genetically predicted gene expression with breast cancer risk finds 48 candidate genes implicated in breast cancer susceptibility, including 14 at novel loci at loci not yet reported for breast cancer.
Journal ArticleDOI

Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies

TL;DR: 3 bias-reduced estimators are proposed and evaluated and corresponding weighted estimators that combine corrected and uncorrected estimators, to reduce selection bias are also proposed and their corresponding CIs are proposed.
Journal ArticleDOI

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia.

TL;DR: The findings confirm the importance of transplanting early before transfusion and indicate that the greatest possible amount of donor marrow (supplemented by stem cells/lymphoid cells derived from the peripheral blood) should be obtained.